Perry, Andrew S. http://orcid.org/0000-0003-3342-6158
Farber-Eger, Eric http://orcid.org/0000-0003-0281-3796
Gonzales, Tomas http://orcid.org/0000-0003-0085-8771
Tanaka, Toshiko
Robbins, Jeremy M.
Murthy, Venkatesh L. http://orcid.org/0000-0002-7901-1321
Stolze, Lindsey K.
Zhao, Shilin
Huang, Shi
Colangelo, Laura A. http://orcid.org/0000-0001-9322-705X
Deng, Shuliang
Hou, Lifang
Lloyd-Jones, Donald M.
Walker, Keenan A. http://orcid.org/0000-0002-5989-9853
Ferrucci, Luigi http://orcid.org/0000-0002-6273-1613
Watts, Eleanor L.
Barber, Jacob L.
Rao, Prashant
Mi, Michael Y.
Gabriel, Kelley Pettee
Hornikel, Bjoern
Sidney, Stephen
Houstis, Nicholas
Lewis, Gregory D.
Liu, Gabrielle Y.
Thyagarajan, Bharat http://orcid.org/0000-0001-6968-6985
Khan, Sadiya S. http://orcid.org/0000-0003-0643-1859
Choi, Bina
Washko, George
Kalhan, Ravi
Wareham, Nick http://orcid.org/0000-0003-1422-2993
Bouchard, Claude http://orcid.org/0000-0002-0048-491X
Sarzynski, Mark A. http://orcid.org/0000-0001-6705-0668
Gerszten, Robert E. http://orcid.org/0000-0002-6767-7687
Brage, Soren http://orcid.org/0000-0002-1265-7355
Wells, Quinn S.
Nayor, Matthew
Shah, Ravi V. http://orcid.org/0000-0002-4471-7156
Article History
Received: 18 October 2023
Accepted: 30 April 2024
First Online: 4 June 2024
Competing interests
: R.V.S. and A.S.P. have applied for a patent related to the findings in this manuscript. R.V.S. is supported in part by grants from the National Institutes of Health and the American Heart Association. In the past 12 months, R.V.S. has served for a consultant for Amgen and Cytokinetics. R.V.S. is a co-inventor on a patent for ex-RNAs signatures of cardiac remodeling and a pending patent on proteomic signatures of fitness and lung and liver diseases. V.L.M. has received grant support from Siemens Healthineers, NIDDK, NIA, NHLBI and AHA. V.L.M. has received other research support from NIVA Medical Imaging Solutions. V.L.M. owns stock in Eli Lilly, Johnson & Johnson, Merck, Bristo-Myers Squibb, Pfizer and stock options in Ionetix. V.L.M. has received research grants and speaking honoraria from Quart Medical. G.D.L. has hospital-based research agreements with from National Institutes of Health R01-HL 151841, R01-HL131029, R01-HL159514, U01HL160278, American Heart Association 15GPSGC-24800006 and SFRN for research involving exercise omics, and has received consulting fees from American Regent, Amgen, Cytokinetics, Boehringer Ingelheim, and Edwards and has received royalties from UpToDate for scientific content authorship related to exercise physiology. M.N. has received speaking honoraria from Cytokinetics. The remaining authors declare no competing interests.